Holger Wirz
Papers
1
Total Citations
60
H-Index
1
About
Holger Wirz is a pioneering researcher at the intersection of biotechnology and pharmaceutical manufacturing, best known for revolutionizing the production of plant-based vaccines and therapeutics. His landmark 2012 study introduced the world’s first fully automated “factory” that leverages tobacco plants as living bioreactors, capable of producing large quantities of complex biologics—including vaccines—within weeks. This breakthrough, which has garnered over 60 citations, harnesses a plant viral vector technology to rapidly express specific therapeutic proteins in the leaves of fast-growing Nicotiana benthamiana plants. Wirz’s work addresses a critical bottleneck in global health: the need for agile, scalable, and cost-effective manufacturing platforms that can respond swiftly to emerging pandemics or bioterrorism threats. By demonstrating that entire production lines—from infiltration to purification—can be automated and standardized, he has laid the groundwork for a new paradigm in biopharmaceutical production. His contributions are particularly notable for bridging the gap between agricultural biotechnology and industrial pharmaceutics, offering a tangible path toward decentralized, on-demand vaccine manufacturing that could transform public health preparedness worldwide.
Research Focus
Key Achievements
Top Papers
- 1Automated Production of Plant-Based Vaccines and Pharmaceuticals60 citations · 2012